Larotrectinib
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for Larotrectinib, covering 2024-12-10 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Larotrectinib for the Treatment of NTRK Amplification Positive, Locally Advanced or Metastatic Solid Tumors [Phase 2]